SLC25A17
Basic information
Region (hg38): 22:40769630-40819399
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (44 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A17 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006358.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 42 | 44 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 42 | 2 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC25A17 | protein_coding | protein_coding | ENST00000435456 | 9 | 49770 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000275 | 0.934 | 125697 | 0 | 51 | 125748 | 0.000203 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.538 | 152 | 172 | 0.885 | 0.00000929 | 1968 |
| Missense in Polyphen | 59 | 67.974 | 0.86798 | 819 | ||
| Synonymous | 0.349 | 59 | 62.5 | 0.944 | 0.00000312 | 628 |
| Loss of Function | 1.70 | 10 | 17.8 | 0.563 | 9.82e-7 | 196 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000326 | 0.000325 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000218 | 0.000217 |
| Finnish | 0.000786 | 0.000786 |
| European (Non-Finnish) | 0.000141 | 0.000141 |
| Middle Eastern | 0.000218 | 0.000217 |
| South Asian | 0.000101 | 0.0000980 |
| Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Peroxisomal transporter for multiple cofactors like coenzyme A (CoA), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) and nucleotide adenosine monophosphate (AMP), and to a lesser extent for nicotinamide adenine dinucleotide (NAD(+)), adenosine diphosphate (ADP) and adenosine 3',5'- diphosphate (PAP). May catalyze the transport of free CoA, FAD and NAD(+) from the cytosol into the peroxisomal matrix by a counter- exchange mechanism. Inhibited by pyridoxal 5'-phosphate and bathophenanthroline in vitro. {ECO:0000269|PubMed:12445829, ECO:0000269|PubMed:22185573}.;
- Pathway
- Peroxisome - Homo sapiens (human);Metabolism of lipids;Alpha-oxidation of phytanate;Purine metabolism;Peroxisomal lipid metabolism;Metabolism;Fatty acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.574
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.106
- hipred
- Y
- hipred_score
- 0.505
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.857
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a17
- Phenotype
Gene ontology
- Biological process
- fatty acid alpha-oxidation;fatty acid beta-oxidation;ADP transport;ATP transport;fatty acid transport;coenzyme A transmembrane transport;FAD transmembrane transport;NAD transmembrane transport;AMP transport
- Cellular component
- peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;membrane
- Molecular function
- adenine nucleotide transmembrane transporter activity;ATP transmembrane transporter activity;protein binding;ADP transmembrane transporter activity;coenzyme A transmembrane transporter activity;FAD transmembrane transporter activity;FMN transmembrane transporter activity;chaperone binding;NAD transmembrane transporter activity;AMP transmembrane transporter activity